Description
Baxter Prismocitrate 18/0 LTS
Solutions for Regional Citrate Anticoagulation (RCA)
Simplify therapy delivery and help enhance patient safety with our solutions purposefully designed for RCA during CRRT
As a pioneer within the field of solutions for RCA, we developed the first ever drug-registered citrate solution indicated as replacement fluid for CRRT using RCA. Committed to innovation and patient safety, our low-concentration citrate-buffered solution for RCA is purposefully designed for CRRT.
How can our solutions for RCA help you optimize CRRT delivery?
Simplified Protocols
Our solutions for RCA, alongside the Prismaflex/PrisMax system and its integrated citrate/calcium management software, offer a choice of simplified protocols in both diffusive and convective therapies.
Enhanced safety
Compared to hypertonic citrate solutions, our low-concentration citrate formulation developed for CRRT helps enhance patient safety and improve metabolic control.
Improved efficiency
Compared to heparin, citrate-buffered formulation may help improve therapy delivery efficiencies by increasing filter life and helping minimize treatment downtime.
Innovative citrate formulation designed for CRRT
Deliver CRRT optimally with our innovative low concentration citrate formulation developed specifically for CRRT in collaboration with HCPs.1,9 Compatible with a wide range of blood flow rates and weight-based protocols, this low-concentration citrate solution contributes to buffer generation and helps minimize the risk of citrate-related metabolic complications, even at high infusion rates.10,11 Due to its physiologic sodium concentration, this formulation also reduces the risk of hypernatremia in patients.
Available commercially for use in CRRT with RCA, our citrate formulation helps maximize efficiencies in workflows for both pharmacy and nursing.
Improved therapy delivery and enhanced efficiency with RCA protocols
Using citrate-based solutions for RCA deliver treatment with reduced risk of bleeding and thrombocytopenia when compared to heparin anticoagulation. With citrate, the risk of circuit loss and incidence of filter failure are also reduced – helping minimize therapy downtime and increase operational efficiency.
Reviews
There are no reviews yet.